A study to investigate a new drug to treat Type 2 Diabetes

Update Il y a 4 ans
Reference: EUCTR2011-000997-77

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of the study is to: • Determine the effect of ranolazine on hemoglobin A1c (HbA1c) after 24 weeks of treatment when added to glimepiride in subjects who have inadequately controlled type 2 diabetes mellitus (T2DM) despite current treatment with stable sulfonylurea (SU) or metformin therapy in addition to diet and exercise


Inclusion criteria

  • Type 2 diabetes mellitus